PMV Pharmaceuticals, Inc. · NASDAQ:PMVP
PMV Pharmaceuticals, Inc. shareholders
As of Sep 30, 2026, 63 institutions reported holding PMV Pharmaceuticals, Inc., 74.8% of its shares. Largest: BML Capital Management, LLC, Tang Capital Management LLC and Samsara Biocapital, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of PMV Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| BML Capital Management, LLC | 7.33M | 9.7% | +2M | Nov 6, 2026 |
| Tang Capital Management LLC | 7.29M | 9.6% | +3.04M | Nov 16, 2026 |
| Samsara Biocapital, LLC | 7.24M | 9.6% | new | Nov 16, 2026 |
| Sio Capital Management, LLC | 3.63M | 4.8% | +1M | Nov 16, 2026 |
| Vanguard | 3.41M | 4.5% | +1.12M | Nov 13, 2026 |
| ADAR1 Capital Management, LLC | 2.7M | 3.6% | +2.5M | Nov 16, 2026 |
| Euclidean Capital LLC | 2.63M | 3.5% | no change | Nov 16, 2026 |
| Two Sigma | 2.43M | 3.2% | +475K | Nov 16, 2026 |
| Adage Capital Partners Gp, L.L.C. | 2.36M | 3.1% | no change | Nov 16, 2026 |
| Acadian Asset Management LLC | 2.29M | 3.0% | +69,585 | Nov 9, 2026 |